Multiple sclerosis

Disease
Favicons?domain=wwwPrime Newswire | November 10, 2009

Transition Therapeutics Announces First Quarter Fiscal 2010 Financial Results

Animal model studies have been performed demonstrating that members of this class of compounds can have a therapeutic effect on CNS diseases including Alzheimer's disease, traumatic brain injury, multiple sclerosis and others.

In this article: Alzheimer's disease, Amortization, Glp-1, Revenue, Metformin, Glucose, and Diabetes

Connections-toggle
Filter by
or